跳至主要内容
临床试验/IRCT20210531051459N3
IRCT20210531051459N3尚未招募3 期

Assessment of the effect of quercetin on glycemic index and inflammatory markers in prediabetes patients: A randomized placebo-controlled clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • People with prediabetes with fasting blood sugar (greater than or equal to 100 and less than 125 mg/dL) or increased blood sugar two hours after prescribing glucose (greater than or equal to 140 and less than 200 mg/dL) or hemoglobin A1C range 5.7% to 6.4%
  • Aged 18 years and older
  • Conscious consent to participate in the study

排除标准

  • Pregnancy and lactation
  • consumption of hypoglycemic drugs
  • Consumption of quercetin in the last three months
  • Taking of crocin and curcumin supplementations
  • History of liver and kidney failures and cardiovascular diseases
  • Cancer and autoimmune diseases
  • Dissatisfaction with participating in the study

研究者

相似试验